skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Rapid and transient stimulation of intracellular reactive oxygen species by melatonin in normal and tumor leukocytes

Journal Article · · Toxicology and Applied Pharmacology
 [1];  [1]; ;  [1];  [2]; ;  [3]; ;  [1];  [1]
  1. Dipartimento di Biologia, Universita di Roma Tor Vergata, via Ricerca Scientifica, 1, 00133 Roma (Italy)
  2. Ambiotec (Italy)
  3. Istituto di Chimica Farmaceutica, Universita di Urbino Carlo Bo (Italy)

Melatonin is a modified tryptophan with potent biological activity, exerted by stimulation of specific plasma membrane (MT1/MT2) receptors, by lower affinity intracellular enzymatic targets (quinone reductase, calmodulin), or through its strong anti-oxidant ability. Scattered studies also report a perplexing pro-oxidant activity, showing that melatonin is able to stimulate production of intracellular reactive oxygen species (ROS). Here we show that on U937 human monocytes melatonin promotes intracellular ROS in a fast (< 1 min) and transient (up to 5-6 h) way. Melatonin equally elicits its pro-radical effect on a set of normal or tumor leukocytes; intriguingly, ROS production does not lead to oxidative stress, as shown by absence of protein carbonylation, maintenance of free thiols, preservation of viability and regular proliferation rate. ROS production is independent from MT1/MT2 receptor interaction, since a) requires micromolar (as opposed to nanomolar) doses of melatonin; b) is not contrasted by the specific MT1/MT2 antagonist luzindole; c) is not mimicked by a set of MT1/MT2 high affinity melatonin analogues. Instead, chlorpromazine, the calmodulin inhibitor shown to prevent melatonin-calmodulin interaction, also prevents melatonin pro-radical effect, suggesting that the low affinity binding to calmodulin (in the micromolar range) may promote ROS production.

OSTI ID:
21272625
Journal Information:
Toxicology and Applied Pharmacology, Vol. 239, Issue 1; Other Information: DOI: 10.1016/j.taap.2009.05.012; PII: S0041-008X(09)00202-6; Copyright (c) 2009 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
Country of Publication:
United States
Language:
English